Oliver Sol

Director Técnico/Científico/I+D en AC IMMUNE SA .

58 años

Health Technology

Consumer Services

Cargos activos de Oliver Sol

Empresas	Cargo	Inicio	Fin
AC IMMUNE SA	Director Técnico/Científico/I+D	-	-
AC IMMUNE SA	Corporate Officer/Principal	-	-

Empresas	Cargo	Inicio	Fin
EUROBIO SCIENTIFIC	Director Técnico/Científico/I+D	-	-
EUROBIO SCIENTIFIC	Consejero General	-	-
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Director Técnico/Científico/I+D	-	-

Internacional

Francia	4
Suiza	2

Operativa

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	1
General Counsel	1

Sectorial

Health Technology	4
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	2
AC IMMUNE SA	Health Technology
EUROBIO SCIENTIFIC	Health Technology

Empresas privadas	2
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Health Technology
Université de Paris XI Paris Sud	Consumer Services

Empresas privadas

Health Technology

Université de Paris XI Paris Sud

Consumer Services